Vanda Pharmaceuticals Inc. announced the appointment of Stephen Ray Mitchell, M.D. to its Board of Directors. Dr. Mitchell currently serves as the Joseph Butenas Professor and Dean for Medical Education at Georgetown University School of Medicine, a position he has held since August 2002. Prior to that, Dr. Mitchell served as Associate Dean for Clinical Curriculum at Georgetown University School of Medicine from 1998 to 2000 and as Senior Associate Dean for Academic Affairs from 2000 until 2002. Previously, Dr. Mitchell served as Program Director for Internal Medicine at Georgetown University School of Medicine from 1992 until 1997, and as Founding Program Director Med-Peds at Georgetown from 1995 until 1999. Dr. Mitchell joined Vanda's Board of Directors, on February 14th, filling the vacancy created by the departure of Michael F. Cola. On February 14, 2020, Michael F. Cola notified the Board of Directors of the company that he would resign from the Board as a Class I director and all committees thereof, effective immediately. On February 14, 2020, the Board also appointed current director Anne Sempowski Ward as a member of the Audit Committee of the Board and appointed current director H. Thomas Watkins as the Chair of the Nominating/Corporate Governance Committee of the Board to replace Mr. Cola in those capacities following his resignation.